Tumor Biology Eventually Prevails in the Optimal Treatment of Perihilar Cholangiocarcinoma
Ann Surg Oncol
.
2024 Oct;31(10):6350-6351.
doi: 10.1245/s10434-024-15868-8.
Epub 2024 Jul 20.
Authors
Dillon Cheung
1
,
Chee-Chee Stucky
1
,
Zhi Ven Fong
2
Affiliations
1
Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA.
2
Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA.
[email protected]
.
PMID:
39031262
DOI:
10.1245/s10434-024-15868-8
No abstract available
Publication types
Editorial
MeSH terms
Bile Duct Neoplasms* / pathology
Bile Duct Neoplasms* / therapy
Humans
Klatskin Tumor* / pathology
Klatskin Tumor* / surgery
Klatskin Tumor* / therapy
Prognosis